Biotechnology Assets S.A. Cash Flow Quality Index
Biotechnology Assets S.A. cash flow quality index. Biotechnology Assets S.A. (BST) has a Cash Flow Quality Index of -0.32x as of June 2023. Operating cash flow of €-935.60K is below net income of €2.95 Million, suggesting accrual-heavy earnings not yet converted to cash. See Biotechnology Assets S.A. (BST) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Biotechnology Assets S.A. (2014–2023)
Cash flow quality index of Biotechnology Assets S.A. from 2014 to 2023. Historical Cash Flow Quality Index for Biotechnology Assets S.A. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Biotechnology Assets S.A. (BST) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Biotechnology Assets S.A. Cash Flow Quality Index by Year (2014–2023)
Biotechnology Assets S.A. cash flow quality index by year from 2014 to 2023. Year-by-year earnings quality comparison for Biotechnology Assets S.A.. For the full cash flow conversion analysis, see Biotechnology Assets S.A. (BST) cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.02x | €47.74K | €2.32 Million | ▲ +105.1% |
| 2014 | -0.40x | €-303.79K | €756.27K | — |